195940.KQ
HK inno.N Corporation
KOE · Healthcare · Medical - Care Facilities · KR
KRW 41,750.00
−3.91%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1078.6B | 1063.2B | 897.1B | 828.9B | 846.5B |
| Cost of Revenue | 589.9B | 591.0B | 462.1B | 452.9B | 497.1B |
| Gross Profit | 488.7B | 472.1B | 435.1B | 376.0B | 349.4B |
| Operating Expenses | |||||
| R&D Expense | 31.0B | 86.6B | 26.6B | 24.4B | 22.5B |
| SG&A Expense | 373.3B | 200.1B | 180.2B | 153.8B | 151.0B |
| General & Admin Expense | (76.9B) | 21.9B | 21.1B | 21.4B | 17.9B |
| Selling & Marketing Expense | — | 178.2B | 159.2B | 132.5B | 133.1B |
| Other Expenses | 130.0B | 74.5B | 140.0B | 131.8B | (613.0M) |
| Total Operating Expenses | 357.7B | 361.2B | 346.8B | 310.0B | 296.9B |
| Cost and Expenses | 949.4B | 952.3B | 808.9B | 763.0B | 794.0B |
| Operating Income (EBIT) | 128.5B | 110.9B | 88.2B | 65.9B | 52.5B |
| Non-Operating | |||||
| Interest Income | 11.8B | 2.8B | 3.0B | 4.0B | 3.4B |
| Interest Expense | 18.4B | 15.6B | 14.7B | 18.7B | 15.1B |
| Net Interest Income | (6.5B) | (12.9B) | (11.7B) | (14.7B) | (11.6B) |
| Other Non-Op Income/Expense | (18.2B) | (19.6B) | (16.5B) | (20.8B) | (14.7B) |
| Non-Operating Income (excl Interest) | — | — | 1.8B | 2.0B | (359.9M) |
| EBT (Pre-Tax Income) | 110.5B | 91.3B | 71.7B | 45.2B | 37.8B |
| Income Tax Expense | 24.6B | 15.6B | 10.2B | (2.0B) | (316.6M) |
| Bottom Line | |||||
| Net Income | 85.8B | 75.7B | 61.6B | 47.2B | 38.1B |
| Earnings from Cont. Ops | 85.8B | 75.7B | 61.6B | 47.2B | 38.1B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 85.8B | 75.7B | 61.6B | 47.2B | 38.1B |
| Per Share | |||||
| Basic EPS | ₩3,030 | ₩2,672 | ₩2,175 | ₩1,666 | ₩1,342 |
| Diluted EPS | ₩3,030 | ₩2,672 | ₩2,175 | ₩1,666 | ₩1,342 |
| Revenue Per Share | ₩38,073 | ₩37,527 | ₩31,682 | ₩29,258 | ₩29,790 |
| Shares | |||||
| Basic Shares Outstanding | 28.3M | 28.3M | 28.3M | 28.3M | 28.4M |
| Diluted Shares Outstanding | 28.3M | 28.3M | 28.3M | 28.3M | 28.4M |
| Profitability Metrics | |||||
| EBITDA | 175.2B | 155.8B | 126.1B | 102.7B | 87.7B |
| D&A | 45.8B | 45.8B | 39.7B | 38.8B | 34.8B |
| EBIT | 128.5B | 110.1B | 86.4B | 63.9B | 52.9B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026